Dasgip

DASGIP Parallel Bioreactors for Unparalleled Results 8-fold Fermentation System Being a provider of first class laboratory equipment for global player in the biopharmaceutical, chemical and food & feed industry, DASGIP AG is a very typical Life Science company in North Rhine-Westphalia. The Juelich based company develops and manufactures state-of-theart Parallel Bioreactor Systems for the cultivation of microbial, animal and human ce

Written byDasgip
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Being a provider of first class laboratory equipment for global player in the biopharmaceutical, chemical and food & feed industry, DASGIP AG is a very typical Life Science company in North Rhine-Westphalia. The Juelich based company develops and manufactures state-of-theart Parallel Bioreactor Systems for the cultivation of microbial, animal and human cells at bench top scale.

Process engineers and research scientists in the biotech, pharmaceutical and chemical industries rely on DASGIP's technology to bring their projects to the next level. Users benefit from increased productivity, high reproducibility and ease of scale up, resulting in accelerated production development cycles.

DASGIP Parallel Bioreactor Systems combine the advantages of easy-tohandle bioreactors with a powerful control software: Up to sixteen highly instrumented reactors can be operated in parallel. As a result, high experimental throughput, minimum input of resources and maximum information output are achieved at the same time.

Individual control of temperature, agitation, pH, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies